3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
8
Breast
7
Gastrointestinal
6
Genitourinary
5
Classical hematology
2
Sarcoma
1
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Dermatologic
1
Conditions
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
16
Cyclophosphamide
11
fludarabine phosphate
10
Peripheral Blood Stem Cell Transplantation
10
Cyclosporine
10
Photochemotherapy
9
Biopsy
9
Whole-Body Irradiation
8
Standard of Care
8
Radiotherapy
8
Educational Status
8
Surgical Procedures, Operative
7
Radiosurgery
7
Mycophenolic Acid
7
Early Intervention, Educational
7
Aminolevulinic Acid
7
Tomography, Optical Coherence
6
Surveys and Questionnaires
6
Psychiatric Rehabilitation
6
Practice Guidelines as Topic
6
Methods
6
Melphalan
6
Filgrastim
6
Sentinel Lymph Node Biopsy
5
Magnetic Resonance Spectroscopy
5
Busulfan
5
Antilymphocyte Serum
5
methyl 5-aminolevulinate
4
Therapeutics
4
Observation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Genetic Counseling
×
Dermatologic
×
Clear all
NCT05225428
2026-05-22
VERDI
Dana-Farber Cancer Institute
Phase NA
Recruiting
1,020 enrolled